If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


Biological Chemistry

Protein Loss Sparks Cartilage Breakdown

An age-related decrease in the production of HMGB2 protein leads to osteoarthritis, a finding that could lead to better therapeutics.

by Stuart A. Borman
January 19, 2009 | A version of this story appeared in Volume 87, Issue 3

The molecular pathway by which cartilage breaks down, causing painful osteoarthritis, is associated with an age-related decrease in the level of a protein called HMGB2, scientists have found (Proc. Natl. Acad. Sci. USA, DOI: 10.1073/pnas.0806062106). The identification of this molecular target could lead to therapeutics for osteoarthritis, which can currently be treated only with palliative drugs that reduce pain and inflammation. “We have found the mechanism that begins to explain how and why aging leads to deterioration of articular cartilage,” says arthritis researcher Martin Lotz of Scripps Research Institute, who carried out the study with Noboru Taniguchi, also of Scripps, and coworkers. The scientists found that HMGB2 is expressed in the surface layer of cartilage in human joints where it supports chondrocytes, which are the cells that produce and maintain cartilage. The study results show that aging leads to lower levels of HMGB2 and the consequent loss of chondrocytes. Preventing the loss of HMGB2-expressing chondrocytes or restoring them to a normal level could be an effective approach to ameliorate osteoarthritis, the researchers write.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.